Impax Asset Management Group
ENFN

Impax Asset Management Group’s Enfusion, Inc. ENFN Stock Holding History

Impax Asset Management Group’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-890,000
Closed -$9.17M – 330
2024
Q4 		$9.17M Buy
890,000
+213,052
+31% +$2.06M 0.04% 169
2024
Q3 		$6.42M Buy
676,948
+136,948
+25% +$1.18M 0.03% 205
2024
Q2 		$4.6M Buy
+540,000
New +$4.94M 0.02% 217

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Impax Asset Management Group's ENFN Position: Q1 2025 in Review

Impax Asset Management Group sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 890,000 shares — an estimated $9.17M sold.

Impax Asset Management Group first reported a position in ENFN in Q2 2024 and held it in 3 quarters. The position peaked at $9.17M in Q4 2024. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Impax Asset Management Group reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Impax Asset Management Group sold 890,000 Enfusion, Inc. shares in Q1 2025, an estimated $9.17M.
  • Impax Asset Management Group first reported a position in Enfusion, Inc. in Q2 2024 and held it in 3 quarters.
  • Impax Asset Management Group's Enfusion, Inc. position peaked at $9.17M in Q4 2024.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Impax Asset Management Group's 13F filing for Q1 2025, filed 29 Apr 2025.